Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year.
Increase in bacterial resistance of streptococcus bacteria, HIV associated pneumonia, rise in prevalence of pneumonia and government initiatives are major factors driving the growth of bacterial pneumonia therapeutics market over the forecast period. According to national statistics UK, in 2013, 5% of deaths in England and Wales are associated due to pneumonia and influenza. Lack of new drugs and improper diagnosis of pneumonia conditions are hindering the growth of this market over the forecast period.
Market Analysis and Insights: Global Bacterial Pneumonia Therapeutics Market
The global Bacterial Pneumonia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bacterial Pneumonia Therapeutics Scope and Market Size
Bacterial Pneumonia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Pneumonia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AstraZeneca
Nabriva Therapeutics
SetLance
Merck
Daiichi Sankyo Company
GlaxoSmithKline
Pfizer
Sanofi Pasteur
Bacterial Pneumonia Therapeutics Breakdown Data by Type
Antibiotics
Vaccines
Bacterial Pneumonia Therapeutics Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Increase in bacterial resistance of streptococcus bacteria, HIV associated pneumonia, rise in prevalence of pneumonia and government initiatives are major factors driving the growth of bacterial pneumonia therapeutics market over the forecast period. According to national statistics UK, in 2013, 5% of deaths in England and Wales are associated due to pneumonia and influenza. Lack of new drugs and improper diagnosis of pneumonia conditions are hindering the growth of this market over the forecast period.
Market Analysis and Insights: Global Bacterial Pneumonia Therapeutics Market
The global Bacterial Pneumonia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bacterial Pneumonia Therapeutics Scope and Market Size
Bacterial Pneumonia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Pneumonia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AstraZeneca
Nabriva Therapeutics
SetLance
Merck
Daiichi Sankyo Company
GlaxoSmithKline
Pfizer
Sanofi Pasteur
Bacterial Pneumonia Therapeutics Breakdown Data by Type
Antibiotics
Vaccines
Bacterial Pneumonia Therapeutics Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bacterial Pneumonia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Bacterial Pneumonia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Vaccines
1.5 Market by Application
1.5.1 Global Bacterial Pneumonia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Mail Order Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bacterial Pneumonia Therapeutics Market Perspective (2015-2026)
2.2 Global Bacterial Pneumonia Therapeutics Growth Trends by Regions
2.2.1 Bacterial Pneumonia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bacterial Pneumonia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Bacterial Pneumonia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bacterial Pneumonia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Bacterial Pneumonia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bacterial Pneumonia Therapeutics Players by Market Size
3.1.1 Global Top Bacterial Pneumonia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Bacterial Pneumonia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Bacterial Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio
3.2.1 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bacterial Pneumonia Therapeutics Revenue in 2019
3.3 Bacterial Pneumonia Therapeutics Key Players Head office and Area Served
3.4 Key Players Bacterial Pneumonia Therapeutics Product Solution and Service
3.5 Date of Enter into Bacterial Pneumonia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bacterial Pneumonia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
5.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bacterial Pneumonia Therapeutics Market Size (2015-2020)
6.2 Bacterial Pneumonia Therapeutics Key Players in North America (2019-2020)
6.3 North America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
6.4 North America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bacterial Pneumonia Therapeutics Market Size (2015-2020)
7.2 Bacterial Pneumonia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Bacterial Pneumonia Therapeutics Market Size (2015-2020)
8.2 Bacterial Pneumonia Therapeutics Key Players in China (2019-2020)
8.3 China Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
8.4 China Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bacterial Pneumonia Therapeutics Market Size (2015-2020)
9.2 Bacterial Pneumonia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bacterial Pneumonia Therapeutics Market Size (2015-2020)
10.2 Bacterial Pneumonia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Bacterial Pneumonia Therapeutics Market Size (2015-2020)
11.2 Bacterial Pneumonia Therapeutics Key Players in India (2019-2020)
11.3 India Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
11.4 India Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bacterial Pneumonia Therapeutics Market Size (2015-2020)
12.2 Bacterial Pneumonia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Bacterial Pneumonia Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Nabriva Therapeutics
13.2.1 Nabriva Therapeutics Company Details
13.2.2 Nabriva Therapeutics Business Overview
13.2.3 Nabriva Therapeutics Bacterial Pneumonia Therapeutics Introduction
13.2.4 Nabriva Therapeutics Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.2.5 Nabriva Therapeutics Recent Development
13.3 SetLance
13.3.1 SetLance Company Details
13.3.2 SetLance Business Overview
13.3.3 SetLance Bacterial Pneumonia Therapeutics Introduction
13.3.4 SetLance Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.3.5 SetLance Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Bacterial Pneumonia Therapeutics Introduction
13.4.4 Merck Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Daiichi Sankyo Company
13.5.1 Daiichi Sankyo Company Company Details
13.5.2 Daiichi Sankyo Company Business Overview
13.5.3 Daiichi Sankyo Company Bacterial Pneumonia Therapeutics Introduction
13.5.4 Daiichi Sankyo Company Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.5.5 Daiichi Sankyo Company Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Bacterial Pneumonia Therapeutics Introduction
13.6.4 GlaxoSmithKline Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Bacterial Pneumonia Therapeutics Introduction
13.7.4 Pfizer Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Sanofi Pasteur
13.8.1 Sanofi Pasteur Company Details
13.8.2 Sanofi Pasteur Business Overview
13.8.3 Sanofi Pasteur Bacterial Pneumonia Therapeutics Introduction
13.8.4 Sanofi Pasteur Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.8.5 Sanofi Pasteur Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bacterial Pneumonia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Bacterial Pneumonia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Vaccines
1.5 Market by Application
1.5.1 Global Bacterial Pneumonia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Mail Order Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bacterial Pneumonia Therapeutics Market Perspective (2015-2026)
2.2 Global Bacterial Pneumonia Therapeutics Growth Trends by Regions
2.2.1 Bacterial Pneumonia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bacterial Pneumonia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Bacterial Pneumonia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bacterial Pneumonia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Bacterial Pneumonia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bacterial Pneumonia Therapeutics Players by Market Size
3.1.1 Global Top Bacterial Pneumonia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Bacterial Pneumonia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Bacterial Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio
3.2.1 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bacterial Pneumonia Therapeutics Revenue in 2019
3.3 Bacterial Pneumonia Therapeutics Key Players Head office and Area Served
3.4 Key Players Bacterial Pneumonia Therapeutics Product Solution and Service
3.5 Date of Enter into Bacterial Pneumonia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bacterial Pneumonia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
5.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bacterial Pneumonia Therapeutics Market Size (2015-2020)
6.2 Bacterial Pneumonia Therapeutics Key Players in North America (2019-2020)
6.3 North America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
6.4 North America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bacterial Pneumonia Therapeutics Market Size (2015-2020)
7.2 Bacterial Pneumonia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Bacterial Pneumonia Therapeutics Market Size (2015-2020)
8.2 Bacterial Pneumonia Therapeutics Key Players in China (2019-2020)
8.3 China Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
8.4 China Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bacterial Pneumonia Therapeutics Market Size (2015-2020)
9.2 Bacterial Pneumonia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bacterial Pneumonia Therapeutics Market Size (2015-2020)
10.2 Bacterial Pneumonia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Bacterial Pneumonia Therapeutics Market Size (2015-2020)
11.2 Bacterial Pneumonia Therapeutics Key Players in India (2019-2020)
11.3 India Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
11.4 India Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bacterial Pneumonia Therapeutics Market Size (2015-2020)
12.2 Bacterial Pneumonia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Bacterial Pneumonia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Bacterial Pneumonia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Bacterial Pneumonia Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Nabriva Therapeutics
13.2.1 Nabriva Therapeutics Company Details
13.2.2 Nabriva Therapeutics Business Overview
13.2.3 Nabriva Therapeutics Bacterial Pneumonia Therapeutics Introduction
13.2.4 Nabriva Therapeutics Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.2.5 Nabriva Therapeutics Recent Development
13.3 SetLance
13.3.1 SetLance Company Details
13.3.2 SetLance Business Overview
13.3.3 SetLance Bacterial Pneumonia Therapeutics Introduction
13.3.4 SetLance Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.3.5 SetLance Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Bacterial Pneumonia Therapeutics Introduction
13.4.4 Merck Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Daiichi Sankyo Company
13.5.1 Daiichi Sankyo Company Company Details
13.5.2 Daiichi Sankyo Company Business Overview
13.5.3 Daiichi Sankyo Company Bacterial Pneumonia Therapeutics Introduction
13.5.4 Daiichi Sankyo Company Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.5.5 Daiichi Sankyo Company Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Bacterial Pneumonia Therapeutics Introduction
13.6.4 GlaxoSmithKline Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Bacterial Pneumonia Therapeutics Introduction
13.7.4 Pfizer Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Sanofi Pasteur
13.8.1 Sanofi Pasteur Company Details
13.8.2 Sanofi Pasteur Business Overview
13.8.3 Sanofi Pasteur Bacterial Pneumonia Therapeutics Introduction
13.8.4 Sanofi Pasteur Revenue in Bacterial Pneumonia Therapeutics Business (2015-2020)
13.8.5 Sanofi Pasteur Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
